| Childhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis AP Groenman, TWP Janssen, J Oosterlaan Journal of the American Academy of Child & Adolescent Psychiatry, 2017 | 273 | 2017 |
| Substance use disorders in adolescents with attention deficit hyperactivity disorder: A 4‐year follow‐up study AP Groenman, J Oosterlaan, N Rommelse, B Franke, H Roeyers, ... Addiction 108 (8), 1503-1511, 2013 | 181 | 2013 |
| The NeuroIMAGE study: a prospective phenotypic, cognitive, genetic and MRI study in children with attention-deficit/hyperactivity disorder. Design and descriptives D von Rhein, M Mennes, H van Ewijk, AP Groenman, MP Zwiers, ... European child & adolescent psychiatry 24, 265-281, 2015 | 170 | 2015 |
| A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood M van Lieshout, M Luman, JWR Twisk, H van Ewijk, AP Groenman, ... European child & adolescent psychiatry 25, 1007-1017, 2016 | 122 | 2016 |
| Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder AP Groenman, J Oosterlaan, NNJ Rommelse, B Franke, CU Greven, ... The British Journal of Psychiatry 203 (2), 112-119, 2013 | 98 | 2013 |
| An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder AP Groenman, LJS Schweren, A Dietrich, PJ Hoekstra Expert Opinion on Drug Safety 16 (4), 455-464, 2017 | 54 | 2017 |
| International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder H Özgen, R Spijkerman, M Noack, M Holtmann, ASA Schellekens, ... European addiction research 26 (4-5), 223-232, 2020 | 38 | 2020 |
| Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder AP Groenman, LJS Schweren, W Weeda, M Luman, SDS Noordermeer, ... European child & adolescent psychiatry 28, 1213-1222, 2019 | 36 | 2019 |
| Meta-analysis: which components of parent training work for children with attention-deficit/hyperactivity disorder? TJ Dekkers, R Hornstra, S van Der Oord, M Luman, PJ Hoekstra, ... Journal of the American Academy of Child & Adolescent Psychiatry 61 (4), 478-494, 2022 | 35 | 2022 |
| Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood S Ilbegi, AP Groenman, A Schellekens, CA Hartman, PJ Hoekstra, ... Journal of neurodevelopmental disorders 10 (1), 1-8, 2018 | 30 | 2018 |
| Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4‐year prospective follow‐up AP Groenman, J Oosterlaan, CU Greven, PJ Vuijk, N Rommelse, ... Journal of Child Psychology and Psychiatry 56 (5), 521-529, 2015 | 24 | 2015 |
| Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder AP Groenman, CU Greven, MMJ Van Donkelaar, A Schellekens, ... Addiction biology 21 (4), 915-923, 2016 | 23 | 2016 |
| Smoking and the developing brain: altered white matter microstructure in attention‐deficit/hyperactivity disorder and healthy controls H van Ewijk*, AP Groenman*, MP Zwiers, DJ Heslenfeld, SV Faraone, ... Human Brain Mapping 36 (3), 1180-1189, 2015 | 23 | 2015 |
| An individual participant data meta-analysis: behavioral treatments for children and adolescents with attention-deficit/hyperactivity disorder AP Groenman, R Hornstra, PJ Hoekstra, L Steenhuis, A Aghebati, ... Journal of the American Academy of Child & Adolescent Psychiatry 61 (2), 144-158, 2022 | 22 | 2022 |
| Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming GH Schoenmacker, AP Groenman, E Sokolova, J Oosterlaan, ... European Neuropsychopharmacology 30, 102-113, 2020 | 16 | 2020 |
| Ageing and heterogeneity regarding autism spectrum conditions: a protocol paper of an accelerated longitudinal study HM Geurts, JAA van Rentergem, T Radhoe, C Torenvliet, ... BMJ open 11 (3), e040943, 2021 | 15 | 2021 |
| Non‐pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta‐analysis E Bruinsma, BJ Van Den Hoofdakker, AP Groenman, PJ Hoekstra, ... Journal of Intellectual Disability Research 64 (8), 561-578, 2020 | 13 | 2020 |
| Parallel age‐related cognitive effects in autism: A cross‐sectional replication study C Torenvliet, AP Groenman, TA Radhoe, JA Agelink van Rentergem, ... Autism Research 15 (3), 507-518, 2022 | 12 | 2022 |
| Age and DRD4 genotype moderate associations between stimulant treatment history and cortex structure in attention-deficit/hyperactivity disorder LJS Schweren, CA Hartman, DJ Heslenfeld, AP Groenman, B Franke, ... Journal of the American Academy of Child & Adolescent Psychiatry 55 (10 …, 2016 | 12 | 2016 |
| Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD HGH Tamminga, L Reneman, A Schrantee, MA Bottelier, C Bouziane, ... European Neuropsychopharmacology 46, 1-13, 2021 | 11 | 2021 |
Jaap OosterlaanProfessor of Pediatric NeuropsychologyVerified email at vu.nl
